Tumor Mutation Burden as a Marker for Molecularly Matched Therapy: More Evidence Needed

Click to increase image sizeClick to decrease image size

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.tandfonline.com/doi/suppl/10.2217/epi-2023-0354

Author contributions

X-Y Meng, conceptualization, data curation, formal analysis, writing – original draft; Q-J Wu, data curation, writing – review editing.

Financial disclosure

X-Y Meng was supported by National Natural Science Foundation of China (82303057) and Natural Science Foundation of Hubei Province of China (2023AFB521). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

X-Y Meng was supported by National Natural Science Foundation of China (82303057) and Natural Science Foundation of Hubei Province of China (2023AFB521). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed